MedPath

MICHAEL PORTMAN

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 2:1
Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (50.0%)
Phase 3
1 (50.0%)

A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease

Phase 2
Completed
Conditions
Mucocutaneous Lymph Node Syndrome
Kawasaki Disease
Interventions
Drug: Placebo
First Posted Date
2009-02-11
Last Posted Date
2023-05-06
Lead Sponsor
Michael Portman
Target Recruit Count
205
Registration Number
NCT00841789
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

🇺🇸

Feinstein Institute for Medical Rsearch, New Hyde Park, New York, United States

🇺🇸

Columbia University Medical Center, New York, New York, United States

and more 5 locations

Study of Triostat in Infants During Heart Surgery

Phase 3
Completed
Conditions
Heart Defects, Congenital
Interventions
Procedure: Cardiopulmonary bypass and cardiac surgery
First Posted Date
2001-12-07
Last Posted Date
2013-08-05
Lead Sponsor
Michael Portman
Target Recruit Count
195
Registration Number
NCT00027417
Locations
🇺🇸

Children's Hospital and Regional Medical Center, Seattle, Washington, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.